Forte Biosciences Inc (FBRX)
0.739
+0.02
(+2.65%)
USD |
NASDAQ |
Apr 25, 16:00
Forte Biosciences Total Assets (Quarterly): 38.98M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.98M |
| September 30, 2023 | 47.88M |
| June 30, 2023 | 31.18M |
| March 31, 2023 | 36.71M |
| December 31, 2022 | 42.00M |
| September 30, 2022 | 45.13M |
| June 30, 2022 | 39.72M |
| March 31, 2022 | 41.30M |
| Date | Value |
|---|---|
| December 31, 2021 | 43.31M |
| September 30, 2021 | 47.39M |
| June 30, 2021 | 52.89M |
| March 31, 2021 | 57.07M |
| December 31, 2020 | 61.24M |
| September 30, 2020 | 22.73M |
| June 30, 2020 | 28.31M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
22.73M
Minimum
Sep 2020
61.24M
Maximum
Dec 2020
42.39M
Average
42.00M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.666M |
| Shareholders Equity (Quarterly) | 35.31M |